Aesthetic Medicine Market

France Aesthetic Medicine Market by Products (Botulinum Toxin and Dermal Filler [Absorbable Dermal Filler and Non-absorbable Dermal Filler] Chemical Peels and Microdermabrasion), End-users (Aesthetic Clinics, Hospitals and Others), and Country - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-3617
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 165
  • Format:
  • Pub. Date: Upcoming
  • Share:

The France aesthetic medicine market size is projected to register a high CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the rising prevalence of alternative beauty and cosmetic products.

France Aesthetic Medicine Market key takeaways

Aesthetic medicine are medical instruments designed to improve the appearance of an individual. These include lasers, skin tightening, body contouring, and wrinkle-reducing devices. They work by assisting in the removal of unwanted fat or wrinkles on various parts of the body such as the abdomen and neck. A steady increase in consumer awareness about these products is resulting from rising demand for minimally invasive surgical procedures that require little recovery time for patients.

In France, it has been observed that patients begin anti-aging techniques and minimally-invasive treatments at a youthful age, and require more invasive procedures to maintain their youthful appearance. Moreover, the rise in disposable income has boosted the demand for cosmetic surgeries. On the other hand, agencies in France are currently not advising the use of non-absorbable products for aesthetic purposes, providing the risk of extremely delayed, uncontrollable, and serious adverse effects.

Market Trends, Drivers, Restraints, and Opportunities

  • Rising demand for cosmetic procedures is estimated to accelerate the growth of the market.
  • Increasing development of minimally noninvasive and invasive aesthetic procedures is expected to boost the aesthetic medicine market.
  • Rising prevalence of obesity in France are key factors fueling the market growth.
  • Growing awareness of aesthetic procedures is estimated to accelerate the growth of the market.
  • Increasing accessibility to advanced aesthetic enhancing procedures that are effective and time-saving is expected to boost the aesthetic medicine market
  • High cost and with medical aesthetic procedures can restrain the growth of the market.
  • Rapid growth in medical tourism and growing awareness about aesthetic specialties is estimated to foster the market growth.

Scope of the Report                          

The report on the aesthetic medicine market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

France Aesthetic medicine Market - France Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Products (Botulinum Toxin and Dermal Filler [Absorbable Dermal Filler and Non-absorbable Dermal Filler] Chemical Peels and Microdermabrasion), and End-users (Aesthetic Clinics, Hospitals and Others)

Country Scope

France

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast.

Key Players Covered in the Report

Johnson & Johnson; AbbVie Inc. (AlLergan Plc); Dermaceutic Laboratoire; Ipsen Pharma and Bioxis Pharmaceuticals.

 

Aesthetic Medicine Market Segment Insights

Dermal filler segment is expected to grow at a rapid pace

Based on products, the market is divided into botulinum toxin and dermal filler, chemical peels and microdermabrasion. The dermal filler segment is further classified as an absorbable dermal filler and non-absorbable dermal filler. The occurrence of skin aging issues is driving the segment growth. Moreover, growing percentage of elderly population and the requirement to look youthful is constantly developing the segment growth.

France Aesthetic Medicine Market by prodcuts

Hospitals segment is anticipated to constitute a key market share

On the basis of end-users, the aesthetic medicine market is categorized as aesthetic clinics, hospitals, and others. The hospitals segment is expected to constitute a key share of the market during the projected period. The hospitals segment is expected to exhibit a rapid growth rate in the coming years owing to rising expenditure on healthcare infrastructure in emerging economies, which has resulted in adoption of advanced aesthetic procedures.

France Aesthetic Medicine Market by end users

Segments

Segments Covered in the Report
The France aesthetic medicine market has been segmented on the basis of

Products

  • Botulinum Toxin
  • Dermal Filler
    • Absorbable Dermal Filler
    • Non-absorbable Dermal Filler
  • Chemical Peel
  • Microdermabrasion
End-users
  • Aesthetic Clinics
  • Hospitals
  • Others
Country
  • France
Key Players
  • Johnson & Johnson
  • AbbVie Inc. (AlLergan Plc)
  • Dermaceutic Laboratoire
  • Ipsen Pharma
  • Bioxis Pharmaceuticals

Competitive Landscape

Key players competing in the aesthetic medicine market are Johnson & Johnson; AbbVie Inc. (AlLergan Plc); Dermaceutic Laboratoire; Ipsen Pharma; and Bioxis Pharmaceuticals.

Companies are engaging in partnerships and focusing on R&D activities to leverage their market share.

In September 2020, Merz Aesthetics, one of the world’s prominent committed medical aesthetics business, declared an association with Gwyneth Paltrow, an Oscar, and Emmy-award-winning entertainer, for the send-off of its worldwide mission for Xeomin®, which is an FDA-approved anti-wrinkle injection for lightening frown lines exclusively purified to remove unnecessary proteins.

In August 2020, a worldwide pioneer energy-based medical gadget organization for aesthetic, ophthalmic, and surgical applications, Lumenis Ltd. declared the launch of NuEra Tight with FocalRF technology, its most recent advancement. The platform offers a breakthrough in personalized non-invasive radiofrequency for optimized body treatments.

France Aesthetic Medicine Market by key players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Aesthetic Medicine Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Aesthetic Medicine Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Aesthetic Medicine Market - Supply Chain
  4.5. Global Aesthetic Medicine Market Forecast
     4.5.1. Aesthetic Medicine Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Aesthetic Medicine Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Aesthetic Medicine Market Absolute $ Opportunity
5. Global Aesthetic Medicine Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Aesthetic Medicine Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Aesthetic Medicine Demand Share Forecast, 2019-2026
6. North America Aesthetic Medicine Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Aesthetic Medicine Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Aesthetic Medicine Demand Share Forecast, 2019-2026
7. Latin America Aesthetic Medicine Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Aesthetic Medicine Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Aesthetic Medicine Demand Share Forecast, 2019-2026
8. Europe Aesthetic Medicine Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Aesthetic Medicine Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Aesthetic Medicine Demand Share Forecast, 2019-2026
9. Asia Pacific Aesthetic Medicine Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Aesthetic Medicine Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Aesthetic Medicine Demand Share Forecast, 2019-2026
10. Middle East & Africa Aesthetic Medicine Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Aesthetic Medicine Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Aesthetic Medicine Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Aesthetic Medicine Market: Market Share Analysis
  11.2. Aesthetic Medicine Distributors and Customers
  11.3. Aesthetic Medicine Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Johnson & Johnson
     11.4.2. AbbVie Inc. (AlLergan Plc)
     11.4.3. Dermaceutic Laboratoire
     11.4.4. Ipsen Pharma
     11.4.5. Bioxis Pharmaceuticals

Segments Covered in the Report
The France aesthetic medicine market has been segmented on the basis of

Products

  • Botulinum Toxin
  • Dermal Filler
    • Absorbable Dermal Filler
    • Non-absorbable Dermal Filler
  • Chemical Peel
  • Microdermabrasion
End-users
  • Aesthetic Clinics
  • Hospitals
  • Others
Country
  • France
Key Players
  • Johnson & Johnson
  • AbbVie Inc. (AlLergan Plc)
  • Dermaceutic Laboratoire
  • Ipsen Pharma
  • Bioxis Pharmaceuticals

Key players competing in the aesthetic medicine market are Johnson & Johnson; AbbVie Inc. (AlLergan Plc); Dermaceutic Laboratoire; Ipsen Pharma; and Bioxis Pharmaceuticals.

Companies are engaging in partnerships and focusing on R&D activities to leverage their market share.

In September 2020, Merz Aesthetics, one of the world’s prominent committed medical aesthetics business, declared an association with Gwyneth Paltrow, an Oscar, and Emmy-award-winning entertainer, for the send-off of its worldwide mission for Xeomin®, which is an FDA-approved anti-wrinkle injection for lightening frown lines exclusively purified to remove unnecessary proteins.

In August 2020, a worldwide pioneer energy-based medical gadget organization for aesthetic, ophthalmic, and surgical applications, Lumenis Ltd. declared the launch of NuEra Tight with FocalRF technology, its most recent advancement. The platform offers a breakthrough in personalized non-invasive radiofrequency for optimized body treatments.

France Aesthetic Medicine Market by key players

Buy Report